Venture Principal
Tim Brent, MBA, has been involved in the bleeding disorders community since 2004. He serves as Venture Principal for Pathway to Cures, carrying out venture investment work. Tim provides contracts oversight, sourcing and evaluating opportunities for investments, developing business and investment cases, drafting and managing the investment transactions with external counsel, and managing post-deal relationships with biotech companies. His previous experience includes clinic and pharmacy operations management and national accounts contracting for a national specialty pharmaceutical distributor. Tim holds a Master of Business Administration from Eastern Illinois University.